The Cost-Effectiveness of Congenital Adrenal Hyperplasia Newborn Screening in Brazil: A Comparison Between Screened and Unscreened Cohorts

Background: Newborn screening for congenital adrenal hyperplasia (CAH-NBS) is not yet a worldwide consensus, in part due to inconclusive evidence regarding cost-effectiveness because the analysis requires an understanding of the short- and long-term costs of care associated with delayed diagnosis. O...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Pediatr
Main Authors: de Miranda, Mirela Costa, Haddad, Luciana Bertocco de Paiva, Trindade, Evelinda, Cassenote, Alex, Hayashi, Giselle Y., Damiani, Durval, Costa, Fernanda Cavalieri, Madureira, Guiomar, de Mendonca, Berenice Bilharinho, Bachega, Tania A. S. S.
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2021
Assuntos:
Pediatrics
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8183606/
https://ncbi.nlm.nih.gov/pubmed/34109139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fped.2021.659492
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares